VivoSim Labs (VIVS) Common Equity (2010 - 2026)

VivoSim Labs has reported Common Equity for 17 years, with the latest figure at -$2.3 million in Q2 2026.

• On a quarterly basis, Common Equity fell 124.6% year-over-year to -$2.3 million in Q2 2026; TTM through Jun 2026 was -$2.3 million, a 124.6% decrease from a year earlier, with the FY2026 full-year figure at -$1.1 million, down 110.47% from the prior year.
• Common Equity was -$2.3 million for Q2 2026 at VivoSim Labs, down from -$1.1 million in the prior quarter.
• The five-year high for Common Equity was $30.2 million in Q1 2022, with the low at -$2.3 million in Q2 2026.
• Average Common Equity over 5 years is $10.5 million, with a median of $7.8 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Common Equity jumped 1120.05% in 2025, then sank 124.6% in 2026.
• Over 5 years, Common Equity stood at $22.3 million in 2022, then plunged by 72.26% to $6.2 million in 2023, then slumped by 94.11% to $364000.0 in 2024, then surged by 1120.05% to $4.4 million in 2025, then sank by 152.83% to -$2.3 million in 2026.
• The last three Common Equity figures came in at -$2.3 million (Q2 2026), -$1.1 million (Q1 2026), and $4.4 million (Q4 2025), per Business Quant data.